Effects of thyroid hormone deficiency on cyclic adenosine 3':5'-monophosphate and control of lipolysis in fat cells.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002462:Cell Membrane / Q000378:metabolism; D002499:Centrifugation, Density Gradient; D000242:Cyclic AMP / Q000032:analysis / Q000378:metabolism*; D004837:Epinephrine / Q000494:pharmacology; D005934:Glucagon / Q000494:pharmacology; D007037:Hypothyroidism / Q000378:metabolism*; D050356:Lipid Metabolism; D008053:Lipid Mobilization / Q000187:drug effects; D008297:Male; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D011441:Propylthiouracil / Q000494:pharmacology; D051381:Rats; D013806:Theophylline / Q000494:pharmacology; D014284:Triiodothyronine / Q000494:pharmacology; D014316:Tritium
D014284:Triiodothyronine; D014316:Tritium; D003994:Bucladesine; D011441:Propylthiouracil; D005934:Glucagon; D013806:Theophylline; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D000262:Adenylyl Cyclases; D004837:Epinephrine